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THE ROLE of the immune system during
oncogenesis by mouse mammary-tumour
virus (MTV) is yet to be completely eluci-
dated. Humoral (Blair et al., 1966; Hilgers
et al., 1971; lhle et al., 1976) and cellular
(Blair, 1976; Creemers & Bentvelzen,
1977; Sigel et al., 1976; Stutman, 1976;
Tagliabue et al., 1978) immunity against
MTV antigens is expressed by MTV-
infected mice relatively early in their life.
However, since it has been established
that immunosuppressive treatments such
as neonatal thymectomy (Martinez, 1964;
Heppner et al., 1968) or injections with
antilymphocyte sera (Lappe & Blair,
1970) reduce the incidence and delay the
appearance of mammary tumours in
MTV-bearing hosts, a possible enhancing
role for the immune system on tumour
growth has been suggested for MTV
tumorigenesis (Prehn & Lappe, 1971).
In an attempt to provide a better under-
standing of the interactions between
immune responses and MTV infections, we
evaluated several in vitro immune para-
meters (Tagliabue et al., 1980) of virgin
C3H/HeN (C3H) female mice infected
with MTV for comparison with genetically
identical C3H/HeN (C3Hf) mice freed of
MTV by foster-nursing. It was found that
C3H mice 14-20 weeks of age have cell-
mediated immunity against MTV anti-
gens, measured as lymphokine production.
By contrast, this reactivity is never detect-
able in younger or older C3H mice or in
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C3Hf mice of any age. Concomitantly to
the lymphokine production, increased
macrophage cytotoxic reactions (Tagliabue
et al., 1980) were found in 14-20-week-old
C3H mice. In parallel to their MTV-related
activation, macrophages from C3H mice
were also able to exert suppressive activi-
ties of lymphoproliferative responses. It
was therefore suggested that the induction
ofsuppressor macrophages could serve as a
possible mechanism by which MTV over-
come the host immune system. Since
evidence in support of the existence of
suppressive mechanisms has so far been
obtained only in in vitro systems, it was
felt of interest to investigate the possible
in vivo relevance of the age-related im-
mune modulation by MTV. For this pur-
pose, C3H and C3Hf female mice of dif-
ferent ages (obtained from the Mammalian
Genetics and Animal Production Service,
National Cancer Institute, Bethesda, Md,
through the courtesy of Dr R. B. Herber-
man, LID, NCI, NIH) were first studied
for their ability to respond to a hetero-
logous antigen such as sheep red blood
cells (SRBC). Four days after the i.p.
injection of 108 SRBC, splenocytes from
immunized mice were tested for their
ability to produce antibodies, using the
technique of Jerne & Nordin (1963). As
shown in the two representative experi-
ments of Table I, C3H mice 14-20 weeks
of age have a statistically significant de-
pression in plaque-forming cells, when
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TABLE I.-Primary anti-SRBC response of
C3H and C3Hf mice of different ages
PFC/spleen*
Exp. grouip Exp.
8-wk C3H 25,400
(11,300-57,300)
8-wk C3Hf 38,370
(18,200-80,900)
14-20-wk C3H 19,000t
(10,700-33,700)
14-20-wk C3Hf 51,700
(46,000-59,400)
36-wk C3H 7,380
(800-67,290)
36-wN%k C3Hf 10,050
(1,590-63,240)
Exp. 2
13,490
(5,800-31,300)
18,420
(4,410-17,560)
8,800t
(4,400-17,560)
42,750
(33,100-55,200)
3,310
(1,420-7,820)
5,960
(3,920-9,060)
* 6 mice per group were injected i.p. with 108
SRBC on Day 0 andl the assay was performed witlh
individual mice on Day +4. Results presented are
geometric means (± s.d.) after logarithmic trans-
formation of the clata.
t P < 0 05 cs coriespon(ling C3Hf mice.
compared to C3Hf mice of the same age,
whereas the response of younger and older
C3H: mice is only slightly less, but not
significantly so, from that of age-matched
C3Hf mice. Thus, a first correlation be-
tween in vitro and in vivo nonspecific
immunodepression by MTV had been
established.
TABLE II.-Latent
Exp. gronp
X *tlk (:311
S wk (:3111'
14 --(2 k C3I1
14 20( wk (:311f
< 14
< 14
We then tried to determine whether the
immunodepression in 14-20-week-old mice
could be of any relevance for the in vivo
growth of transplanted tumours. We used
a spontaneous mammarycarcinoma (MAT-
21 tumour) from a 14-month-old virgin
C3H mouse. This tumour was maintained
by s.c. injection of trocar fragments and
used in this study at the second transplant
generation. Single-cell suspensions ob-
tained by mechanical teasing were filtered,
washed in serum-free phosphate-buffered
saline and counted before s.c. injection.
Latent period (LP) was recorded when the
tumour diameter measured by caliper
was 5 mm. C3H and C3Hf mice 8 and 14-
20 weeks of age were transplanted s.c.
with variable numbers of MAT-21 car-
cinoma cells. Table II shows that the
tumour median latent period (MLP) varied
not only with the number of tumour cells
injected, as expected, but also in relation
to age and status ofMTVinfection. In fact,
younger C3H and C3Hf mice presented
shorter MLPs than corresponding older
mice. Moreover, in C3H mice the tumour
appeared earlier than in C3HF mice.
Similarly the median survival times (MST)
of C3H mice of any age were shorter than
2 1
(16-48)
;l A
35 A
(1656) -
~r.
28
(21 -45) -\
42
(24-102)
< 14
< 14
c
53
(7 -70) A
A
fi3a .- _
(35-92))
6.
A
(43 90) A
99
(63 150)
a ) 11) long-term sun iors.
Statisti al signiiticaice was asscssedbl the MIantn WhitnecX' test. At least 1( mice/group were use(l.
period (MLP) of C3Hand C3Hf mice of different ages transplanted
with MAT-21 mammary tumour
\ILP in (lays (range) at'ter s.c. ilejctioni ot
10' cells 10 () cells 1 04 Ccils
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TABLE III.-Survival time (MST) ofC3H andC3Hfmiceofdifferent ages bearingMAT-21
tumour
ISI1 in (lays (range) al'ter s.c. injection ol
Exp. group 10* cells 1Os cells 10(' cells
8Xk (C3ll 49 _
(34-85) A
- A
8 wvk C3Ht 61 -_7 _
(.,jI-9()) A
14-20 vk C3H 4(0 2
(28-50) A
z
14-20 svk C3Hf 60 -
(45-108)
A
C?
A
o~
o
93
A
?~
(73-138)
104 - _
(68-125) A
l A
81 2867)
(85 167)
88
(64-109) A
Xo ;D 145 -
(98-153)
A
op
a 2/1 0 long-term survivors.
Statistical significance was assessed by the Mann-Whitncy U test. At least 10 mice/group were use(l.
those for C3Hfmice injected with variable
numbers of MAT-21 tumour cells (Table
III). Thus these results indicate that C3H
mice are more susceptible to the MAT-21
tumour growth than C3Hf mice. This
agrees with our previous findings with
another mammary carcinoma (Tagliabue
et al., 1978, 1979) and with the observation
of 0th & Sabolovic (1977) indicating that
mammary tumours are more easily trans-
plantable in histocompatible recipients
when these have been reared on MTV-
containing milk.
Furthermore, the observation that the
MSTs of 14-20-week-old C3H mice were
significantly shorter than those ofyounger
C3H mice (Table III) is of particular
interest. In fact, the higher susceptibility
to the MAT-21 tumour growth of 14-20-
week-old C3H mice can be considered
further evidence ofthe in vivo relevance of
the immunodepression caused by the
MTV infection. Even though mammary
tumours have been shown to be weakly
immunogenic inMTV-infected mice (Prehn
& Lappe, 1971) a cell-mediated immune
response can be detected against non-viral
tumour antigens (Vaage, 1968; Stutman,
1976; Tagliabue et al., 1979). Thus the
nonspecific immunodepression we found
in 14-20-week-old C3H mice could contri-
bute to the elimination of the non-viral
anti-tumour immunity of these mice. This
hypothesis is further supported by our
results with the 3-methylcholanthrene
1023 fibrosarcoma of C3H mice. This
MTV-free tumour was previously shown
to be immunogenic in C3Hf mice (Zbar
et al., 1980). Table IV shows that no dif-
ference could be detected between C3H
and C3Hf mice of any age when trans-
planted with the 1023 fibrosarcoma.
We previously observed that cell-
mediated immunity against non-viral anti-
TABLE IV. Survival time of C3H and
C3Hf mice of different ages bearing 1023
fibrosarcoma
MST in (lays (range)
after s.c. injection of
Exp. group 105 cells 104 cells
8-wk C3H 44 53
(25-80) (35-79)*
8-wk C3Hf 38 44
(27-97) (25-107)
14-20-wk C3H 40 50
(32-74) (25-77)*
14-20-wk C3Hf 38 42
(31-62) (31-83)*
* 2/10 long-term survivors.
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gens is developed only when the tumour
becomes as large as 0 5-1 g (Tagliabue et
al., 1979). This mass can only be reached
several days after the mammary tumour
becomes palpable. Thus the discrepancy
between MLPs and MSTs, the former
being shorter in 8-week-old C3H mice and
the latter shorter in 14-20-week-old C3H
mice (Tables II and III), and the results
with the 1023 fibrosarcoma, further sug-
gest that the immune depression of the
older C31H mice acts preferentially on
those mechanisms regulating the tumour
growth after the host has been able to
develop the specific immune response
against tumour antigens.
In conclusion, these results indicate
that the MTV infection induces a sig-
nificant in vivo immunodepression that
can be relevant to the survival of mice
bearing transplanted mammary tumours.
Whether this effect ofMTV on the immune
system is also important for the develop-
ment of virus-induced tumours which
become "clinically" evident later in life,
remains to be elucidated.
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